Rockefeller Capital Management
RNAM

Rockefeller Capital Management’s Avidity Biosciences RNAM Stock Holding History

Rockefeller Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-474
Closed -$34.2K – 4850
2025
Q4 		$34.2K Buy
474
+91
+24% +$5.88K ﹤0.01% 3252
2025
Q3 		$16.7K Buy
+383
New +$15.5K ﹤0.01% 3431

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Rockefeller Capital Management's RNAM Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 474 shares — an estimated $34.2K sold.

Rockefeller Capital Management first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $34.2K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Rockefeller Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 474 Avidity Biosciences shares in Q1 2026, an estimated $34.2K.
  • Rockefeller Capital Management first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
  • Rockefeller Capital Management's Avidity Biosciences position peaked at $34.2K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.